Trinity Biotech, CGM
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced compelling ...
Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its ...
Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based diagnostic company with a market capitalization of $23.7 million and current trading price of $1.32, is evaluating the potential effects of a recent ...
How does the funding impact Trinity Biotech's CGM technology development? The new liquidity supports the ongoing development of Trinity Biotech’s innovative continuous glucose monitoring ...
“The additional liquidity will support critical initiatives, including the development of our CGM technology, and further positions Trinity Biotech for growth and profitability. Combined with ...
The study assessed the analytical performance of CGM technology enhancements implemented by Trinity Biotech since acquiring t -Metabolomics Diagnostics, a deep-tech machine learning diagnostic ...
"The additional liquidity will support critical initiatives, including the development of our CGM technology, and further positions Trinity Biotech for growth and profitability. Combined with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback